Pfizer Fires a Vice President Who Criticized Company’s Sales Practices Fri, 2 Dec 2005 Word of the day: “The Department of Justice simply does not have enough lawyers and investigators to handle the volume of false claims act suits coming its way. There are right now 150 cases under seal…
Grassley Calls for Safety Review /Unsafe Drugs Marketed to Consumers / FDA Lacks Leadership Sun, 19 Dec 2004 “We expect the FDA to not put a drug on the market that’s not safe. And you can’t compromise safety, regardless of how much pressure there is to get more drugs on…
Philadelphia Daily News Pharma Influence: Penn Psychiatrist Files Whistleblower Lawsuit – Investigtion Confirms Medicare Chief Lied to Congress Wed, 7 Jul 2004 “Drug companies not only write checks to hospitals, they write checks to politicians…They write checks to both sides of the aisle.” Two separate news reports provide a glimpse…
To view AHRP news and infomails from 2006, please visit our new site. Infomails Subscribe to AHRP’s infomails At FDA, Graham is still the whistle-blower Loss of Trust: Big Drug Makers See Sales Decline With Their Image War hero’s death in clinical trial follows years of FDA neglect European perspective:…
TIME inquiry finds top officials at vital gov agencies lack credentials for the job Date: Wed, 28 Sep 2005 The New York Times reports today that the mystery of Lester Crawford’s abrupt resignation as head of the FDA “fueled speculation that he had investments in companies regulated by the FDA."…
Just Say No – Forbes Tue, 16 Nov 2004 When Mrs. Nancy Reagan coined the phrase, Just Say No, she was referring to illicit drug pushers. The current Forbes cover story–Just Say No–refers to the prescription drug industry. "In a perverse kind of symbiosis, the cascade of disease and medical…
Medicare Will cover New Treatments But Patients Will be Required to Enroll in Clinical Trials Fri, 5 Nov 2004 Dr. Mark McClellan, Director of Medicare, estimates that of Medicare’s $320 billion budget, “a third of all medical expenditures are for unnecessary or ill-advised treatments.” Medicare’s chief medical officer, Dr. Sean…
AHRP Speaks Out AHRP Press Briefing 9/14/04: Antidepressants & suicide-related risks for children Open Letter to NIMH re Prozac & Concealed Suicide Attempts Open Letter to Officials at NIMH AHRP Briefing 2/2/04: Scientists present suicide evidence Conflicts of Interest policy – New York Times Phase I Drug Trials Used Foster…
The Crawford Resignation Mystery Sat, 24 Sep 2005 Merrill Goozner of Center for Science in the Public Interest provides insight into what may lie behind the sudden resignation of FDA Commissioner, Lester Crawford. Goozner surggests, “One possible clue to the administration’s thinking comes from the appointment of Andrew von Eschenbach,…
Paxil induced suicides in US quantified_Glaxo Faces criminal action in UK over “suicide” pills_Times Mon, 7 Jun Law enforcement is finally catching up with drug companies who, for years, concealed evidence of a drug-related suicide risk for some children and adults who take an antidepressant. The law requires the companies…
Medicare Rx Drug Bill Shaped by Drug Industry Blocks Elderly Bargaining Power – NYT Fri, 5 Sep 2003 A drug industry lobbyist is quoted in The New York Times stating: “Having both houses of Congress Republican-controlled was great. Like in Monopoly, when you get to add hotels.” The Medicare prescription…
OHRP Response to AHRP re: Surrogate Consent to Research Office of the Secretary Department of Health & Human Services Office of Public Health and Science Office for Human Research Protections Rockville, Maryland E-mail: mcarome@osophs.dhhs.gov August 28, 2002 Vera Hassner Sharav President, The Alliance for Human Research Protection John H. Noble,…
